Abstract
Herein, we succinctly review mechanisms underlying self-tolerance and the roles of dendritic leukocytes (DCs) in T-cell tolerance to self and foreign antigens. We also consider the properties of naturally arising and other populations of regulatory T cells (Treg), together with growing evidence that interplay between DCs and Treg cells can sustain antigen-specific tolerance. B-cell tolerance and the role of hematopoietic cell chimerism in the induction and maintenance of tolerance are also discussed, as is the impact of cosignaling pathway manipulation on tolerance induction. This overview also surveys prospects for technological advances in the monitoring and prediction of tolerance and the application of genomic and proteomic analysis. In addition, we consider potential novel therapeutic targets for promotion of tolerance induction.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Lotze, M. T. and Thomson, A. W. (2005) Monitoring Immunity. Elsevier-Academic Press, New York. pp. 1–722.
Goodnow, C. C., Sprent, J., Fazekas de St. Groth, B., and Vinuesa, G. (2005) Cellular and genetic mechanisms of self tolerance and autoimmunity. Nature 435, 590–597.
Nemazee, D. and Hogquist, K. A. (2003) Antigen receptor selection by editing or downregulation of V(D)J recombination. Curr. Opin. Immunol. 15, 182–189.
Kronenberg, M. and Rudensky, A. (2005) Regulation of immunity by self-reactive T cells. Nature 435, 598–604.
Liston, A., Lesage, S., Wilson, J., Peltonen, L., and Goodnow, C. C. (2003) Aire regulates negative selection of organ-specific T cells. Nat. Immunol. 4, 350–354.
Thorsby, E. and Lie, B. A. (2005) HLA associated genetic predisposition to autoimmune diseases: genes involved and possible mechanisms. Transpl. Immunol. 14, 175–182.
Steinman, R. M., Hawiger, D., and Nussenzweig, M. (2003) Tolerogenic dendritic cells. Annu. Rev. Immunol. 21, 685–711.
Morelli, A. E. and Thomson, A. W. (2003) Dendritic cells: regulators of alloimmunity and opportunities for tolerance induction. Immunol. Rev. 196, 125–146.
Fu, F., Li, Y., Qian, S., et al. (1996) Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86t-) prolong cardiac allograft survival in nonimmunosuppressed recipients. Transplantation 62, 659–665.
Lutz, M. Suri, R. M., Niimi, M., et al. (2000) Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo. Eur. J. Immunol. 30, 1813–1822.
Lu, L., Li, W., Fu, F., et al. (1997) Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival. Transplantation 64, 1808–1815.
Sato, K., Yamashita, N., Yamashita, N., Baba, M., and Matsuyama, T. (2003) Regulatory dendritic cells protect mice from murine acute graft-versus-host disease and leukemia relapse. Immunity 18, 367–379.
Roelen, D. L., Schuurhuis, D. H., van den Boogaardt, D. E., et al. (2003) Prolongation of skin graft survival by modulation of the alloimmune response with alternatively activated dendritic cells. Transplantation 76, 1608–1615.
Peche, H., Trinite, Martinet, and Cuturi, M. (2005) Prolongation of heart allograft survival by immature dendritic cells generated from recipient type bone marrow progenitors. Am. J. Transplant. 5, 255–267.
Beriou, G., Peche, H., Guillonneau, C., Merieau, E., and Cuturi, M. C. (2005) Donor-specific allograft tolerance by administration of recipient-derived immature dendritic cells and suboptimal immunosuppression. Transplantation 79, 969–972.
Albert, M. L., Jegathesan, M., and Darnell, R. B. (2001) Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells. Nat. Immunol. 2, 1010–1017.
Verhasselt, V., Vosters, O., Beuneu, C., Nicaise, C., Stordeur, P., and Goldman, M. (2004) Induction of FOXP3-expressing regulatory CD4pos T cells by human mature autologous dendritic cells. Eur. J. Immunol. 34, 762–772.
Menges, M., Rossner, S., Voigtlander, C., et al. (2002) Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity. J. Exp. Med. 195, 15–21.
Tomasoni, S., Aiello, S., Cassis, L., et al. (2005) Dendritic cells genetically engineered with adenoviral vector encoding dnIKK2 induce the formation of potent CD4+ T-regulatory cells. Transplantation 79, 1056–1061.
Tarbell, K. V., Yamazaki, S., Olson, K., Toy, P., and Steinman, R. M. (2004) CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J. Exp. Med. 199, 1467–1477.
Yamazaki, S., Iyoda, T., Tarbell, K., et al. (2003) Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells. J. Exp. Med. 198, 235–247.
Fairchild, P. J., Nolan, K. R., Cartland, S., and Waldmann, H. (2005) Embryonic stem cells: a novel source of dendritic cells for clinical applications. Int. Immunopharmacol. 5, 13–21.
Colonna, M., Trinchieri, G., and Liu, Y. J. (2004) Plasmacytoid dendritic cells in immunity. Nat. Immunol. 5, 1219–1226.
De Heer, H. J., Hammad, H., Soullie, T., et al. (2004) Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J. Exp. Med. 200, 89–98.
Gilliet, M., Boonstra, A., Paturel, C., et al. (2002) The development of murine plasmacytoid dendritic cell precursors is differentially regulated by FLT3-ligand and granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 195, 953–958.
Moseman, E. A., Liang, X., Dawson, A. J., et al. (2004) Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells. J. Immunol. 173, 4433–4442.
Fugier-Vivier, I. J., Rezzoug, F., Huang, Y., et al. (2005) Plasmacytoid precursor dendritic cells facilitate allogeneic hematopoietic stem cell engraftment. J. Exp. Med. 201, 373–383.
Abe, M., Wang, Z., De Creus, A., and Thomson, A. W. (2005) Plasmacytoid dendritic cell precursors induce allogeneic T cell hyporesponsiveness and prolong heart graft survival. Am. J. Transplant. 5, 1808–1819.
Bjorck, P., Coates, P. T., Wang, Z., Duncan, F. J., and Thomson, A. W. (2005) Promotion of long-term heart allograft survival by combination of mobilized donor plasmacytoid dendritic cells and anti-CD 154 monoclonal antibody. J. Heart Lung Transplant. 24, 1118–1120.
Lutz, M. B. and Schuler, G. (2002) Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol. 23, 445–449.
Bluestone, J. A. and Abbas, A. K. (2003) Natural versus adaptive regulatory T cells. Nat. Rev. Immunol. 3, 253–257.
Hsieh, S., Liang, Y., Tyznik, A. J., Self, S. G., Liggitt, D., and Rudensky, A. Y. (2004) Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors. Immunity 21, 267–277.
Fontenot, J. D., Rasmussen, J. P., Williams, L. M., Dooley, J. L., Farr, A. G., and Rudensky, A. Y. (2005) Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22, 329–341.
Fontenot, J. D., Rasmussen, J. P., Gavin, M. A., and Rudensky, A. Y. (2005) A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. 6, 1142–1151.
Fontenot, J. D., Dooley, J. L., Farr, A. G., and Rudensky, A. Y. (2005) Developmental regulation of Foxp3 expression during ontogeny. J. Exp. Med. 202, 901–906.
Shevach, E. M. (2002) CD4+ CD25+ suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2, 389–400.
von Boehmer, H. (2005) Mechanisms of suppression by suppressor T cells. Nat. Immunol. 6, 338–344.
Grossman, W. J., Verbsky, J. W., Barchet, W., Colonna, M., Atkinson, J. P., and Ley, T. J. (2004) Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity 21, 589–601.
Bendelac, A. (1995) Mouse NK1+ T cells. Curr. Opin. Immunol. 7, 367–374.
Cui, J., Shin, T., Kawano, T., et al. (1997) Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. Science 278, 1623–1626.
Gombert, J. M., Herbelin, A., Tancrede-Bohin, E., Dy, M., Carnaud, C., and Bach, J. F. (1996) Early quantitative and functional deficiency of NK1+−like thymocytes in the NOD mouse. Eur. J. Immunol. 26, 2989–2998.
Godfrey, D. I., Hammond, K. J., Poulton, L. D., Smyth, M. J., and Baxter, A. G. (2000) NKT cells: facts, functions and fallacies. Immunol. Today 21, 573–583.
Wilson, S. B. and Delovitch, T. L. (2003) Janus-like role of regulatory iNKT cells in autoimmune disease and tumour immunity. Nat. Rev. Immunol. 3, 211–222.
Jiang, H. and Chess, L. (2004) An integrated view of suppressor T cell subsets in immunoregulation. J. Clin. Invest. 114, 1198–1208.
Wilson, S. B., Kent, S. C., Patton, K. T., et al. (1998) Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes. Nature 391, 177–181.
Groux, H., O’Garra, A., Bigler, M., et al. (1997) A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389, 737–742.
Hawrylowicz, M. and O’Garra, A. (2005) Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma. Nat. Rev. Immunol. 5, 271–283.
Roncarolo, M. G., Bacchetta, R., Bordignon, C., Narula, S., and Levings, M. K. (2001) Type 1 T regulatory cells. Immunol. Rev. 182, 68–79.
Gregori, S., Bacchetta, R., Hauben, E., Battaglia, M., and Roncarolo, M. G. (2005) Regulatory T cells: prospective for clinical application in hematopoietic stem cell transplantation. Curr. Opin. Hematol. 12, 451–456.
Battaglia, M., Stabilini, A., Draghici, E., et al. (2006) Rapamycin and interleukin-10 treatment induces T regulatory type 1 cells that mediate antigen-specific transplantation tolerance. Diabetes 55, 40–49.
Sarantopoulos, S., Lu, L., and Cantor, H. (2004) Qa-1 restriction of CD8+ suppressor T cells. J. Clin. Invest. 114, 1218–1221.
Kumar, V. (2004) Homeostatic control of immunity by TCR peptide-specific Tregs. J. Clin. Invest. 114, 1222–1226.
Jiang, S., Tugulea, S., Pennesi, G., et al. (1998) Induction of MHC-class I restricted human suppressor T cells by peptide priming in vitro. Hum. Immunol. 59, 690–699.
Chang, C. C., Ciubotariu, R., Manavalan, J. S., et al. (2002) Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat. Immunol. 3, 237–243.
Najafian, N., Chitnis, T., Salama, A. D., et al. (2003) Regulatory functions of CD8+CD28-T cells in an autoimmune disease model. J. Clin. Invest. 112, 1037–1048.
Bluestone, J. A. (2005) Regulatory T-cell therapy: is it ready for the clinic? Nat. Rev. Immunol. 5, 343–349.
Gilliet, M. and Liu, Y. J. (2002) Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J. Exp. Med. 195, 695–704.
Jonuleit, H., Schmitt, E., Schuler, G., Knop, J., and Enk, A. H. (2000) Induction of interleukin 10-producing, nonproliferating CD4+ T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 192, 1213–1222.
Levings, M. K., Gregori, S., Tresoldi, E., Cazzaniga, S., Bonini, C., and Roncarolo, M. G. (2005) Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells. Blood 105, 1162–1169.
Tan, P. H., Sagoo, P., Chan, C., et al. (2005) Inhibition of NF-kappaB and oxidative pathways in human dendritic cells by antioxidative vitamins generates regulatory T cells. J. Immunol. 174, 7633–7644.
Taner, T., Hackstein, H., Wang, Z., Morelli, A. E., and Thomson, A. W. (2005) Rapamycin-treated, alloantigen-pulsed host dendritic cells induce Ag-specific T cell regulation and prolong graft survival. Am. J. Transplant. 5, 228–236.
Hackstein, H. and Thomson, A. W. (2004) Dendritic cells: emerging pharmacological targets of immunosuppressive drugs. Nat. Rev. Immunol. 4, 24–35.
Mirenda, V., Berton, I., Read, J., et al. (2004) Modified dendritic cells coexpressing self and allogeneic major histocompatability complex molecules: an efficient way to induce indirect pathway regulation. J. Am. Soc. Nephrol. 15, 987–997.
Gregori, S., Casorati, M., Amuchastegui, S., Smiroldo, S., Davalli, A. M., and Adorini, L. (2001) Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J. Immunol. 167, 1945–1953.
Min, W. P., Zhou, D., Ichim, T. E., et al. (2003) Inhibitory feedback loop between tolerogenic dendritic cells and regulatory T cells in transplant tolerance. J. Immunol. 170, 1304–1312.
Thomas, J. M., Contreras, J. L., Jiang, X. L., et al. (1999) Peritransplant tolerance induction in macaques: early events reflecting the unique synergy between immunotoxin and deoxyspergualin. Transplantation 68, 1660–1673.
Dhodapkar, M. V. and Steinman, R. M. (2002) Antigen-bearing immature dendritic cells induce peptide-specific CD8(+) regulatory T cells in vivo in humans. Blood 100, 174–177.
Healy, J. I. and Goodnow, C. C. (1998) Positive versus negative signaling by lymphocyte antigen receptors. Annu. Rev. Immunol. 16, 645–670.
Fields, M. L. and Erikson, J. (2003) The regulation of lupus-associated autoantibodies: immunoglobulin transgenic models. Curr. Opin. Immunol. 15, 709–717.
Benschop, R. J., Aviszus, K., Zhang, X., Manser, T., Cambier, J. C., and Wysocki, L. J. (2001) Activation and anergy in bone marrow B cells of a novel immunoglobulin transgenic mouse that is both hapten specific and autoreactive. Immunity 14, 33–43.
Lesley, R., Xu, Y., Kalled, S. L., et al. (2004) Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF. Immunity 20, 441–453.
Martin, F. and Chan, A. C. (2004) Pathogenic roles of B cells in human autoimmunity; insights from the clinic. Immunity 20, 517–527.
Silverman, G. J. and Carson, D. A. (2003) Roles of B cells in rheumatoid arthritis. Arthritis Res. Ther. 5, S1–S6.
Chentoufi, A. A., Nizet, Y., Havaux, X., et al. (1999) Differential effects of injections of anti-mu and anti-delta monoclonal antibodies on B-cell populations in adult mice: regulation of xenoreactive natural antibody-producing cells. Transplantation 68, 1728–1736.
Chentoufi, A. A., Nizet, Y., Havaux, X., Nisol, F., Bazin, H., and Latinne, D. (2000) B-Cell suppression in adult mice injected with anti-delta followed by antimu mAb. Cell. Immunol. 205, 40–51.
Finkelman, E D., Holmes, J. M., Dukhanina, O. L, and Morris, S. C. (1995) Cross-linking of membrane immunoglobulin D, in the absence of T cell help, kills mature B cells in vivo. J. Exp. Med. 181, 515–525.
Flynn, J. M. and Byrd, J. C. (2000) Campathmonoclonal antibody therapy. Curr. Opin. Oncol. 12, 574–581.
Sykes, M., Shimizu, I., and Kawahara, T. (2005) Mixed hematopoietic chimerism for the simultaneous induction of T and B cell tolerance. Transplantation 79, S28–S29.
Monroe, J. G. (2005) Molecular mechanisms regulating B cell responsiveness and tolerance. Transplantation 79, S12–S13.
Fuchs, E. J. and Matzinger, P. (1992) B cells turn off virgin but not memory T cells. Science 258, 1156–1159.
Raimondi, G., Zanoni, I., Citterio, S., Ricciardi-Castagnoli, P., and Granucci, F. (2006) Induction of peripheral T cell tolerance by antigen presenting B cells. I. Relevance of antigen presentation persistence. J. Immunol. 176, 4012–4020.
Raimondi, G., Zanoni, I., Citterio, S., Ricciardi-Castagnoli, P., and Granucci, F. (2006) Induction of peripheral T cell tolerance by antigen presenting B cells. II Chronic antigen presentation overrules antigen presenting B cell activation. J. Immunol. 176, 4021–4028.
Starzl, T. E. (2004) Chimerism and tolerance in transplantation. Proc. Natl. Acad. Sci. USA 101, 14,607–14,614.
Bonilla, W. V., Geuking, M. B., Aichele, P., Ludewig, B., Hengartner, H., and Zinkernagel, R. M. (2006) Microchimerism maintains deletion of the donor cell-specific CD8 T cell repertoire. J. Clin. Invest. 116, 156–162.
Fehr, T. and Sykes, M. (2004) Tolerance induction in clinical transplantation. Transpl. Immunol. 13, 117–130.
Bruno, D. A., Dhanireddy, K. K., and Kirk, A. D. (2005) Challenges in therapeutic strategies for transplantation: where now from here? Transpl. Immunol. 15, 149–155.
Claas, F. (2004) Chimerism as a tool to induce clinical transplantation tolerance. Curr. Opin. Immunol. 16, 578–583.
Sykes, M. and Nikolic, B. (2005) Treatment of severe autoimmune disease by stem-cell transplantation. Nature 435, 620–627.
Adams, A. B., Pearson, T. C., and Larsen, C. P. (2003) Heterologous immunity: an overlooked barrier to tolerance. Immunol. Rev. 196, 147–160.
Kurtz, J., Wekerle, T., and Sykes, M. (2004) Tolerance in mixed chimerism: a role for regulatory cells? Trends Immunol. 25, 518–523.
Hess, A. D. (2006) Modulation of graft-versus-host disease: role of regulatory T lymphocytes. Biol. Blood Marrow Transplant. 12, 13–21.
Porta, M. D., Rigolin, G. M., Alessandrino, E. P., et al. (2004) Dendritic cell recovery after allogeneic stem-cell transplantation in acute leukemia: correlations with clinical and transplant characteristics. Eur. J. Haematol. 72, 18–25.
Reddy, V., Iturraspe, J. A., Tzolas, A. C., Meier-Kriesche, H. U., Schold, J., and Wingard, J. R. (2004) Low dendritic cell count after allogeneic hematopoietic stem cell transplantation predicts relapse, death, and acute graft-versus-host disease. Blood 103, 4330–4335.
Nachbaur, D. and Kircher, B. (2005) Dendritic cells in allogeneic hematopoietic stem cell transplantation. Leuk. Lymphoma 46, 1387–1396.
Lambert, N. and Nelson, J. L. (2003) Microchimerism in autoimmune disease: more questions than answers? Autoimmun. Rev. 2, 133–139.
Greenwald, R. J., Freeman, G. J., and Sharpe, A. H. (2005) The B7 family revisited. Annu. Rev. Immunol. 23, 515–548.
Quezada, S. A., Jarvinen, L. Z., Lind, E. R, and Noelle, R. J. (2004) CD40/CD154 interactions at the interface of tolerance and immunity. Annu. Rev. Immunol. 22, 307–328.
Wang, Z., Larregina, A., Shufesky, W., et al. (2006) Use of the inhibitory effect of apoptotic cells on dendritic cells for graft survival via T cell deletion and regulatory T cells. Am. J. Transplant. 6, 1297–1231.
Thomson, A. W., Mazariegos, G. V., Reyes, J., et al. (2001) Monitoring the patient off immunosuppression. Conceptual framework for a proposed tolerance assay study in liver transplant recipients. Transplantation 72, S13–S22.
Mazariegos, G. V., Zahorchak, A. F, Reyes, J., Chapman, H., Zeevi, A., and Thomson, A. W. (2005) Dendritic cell subset ratio in tolerant, weaning and non-tolerant liver recipients is not affected by extent of immunosuppression. Am. J. Transplant. 5, 314–322.
Mazariegos, G. V., Zahorchak, A. R, Reyes, J., et al. (2003) Dendritic cell subset ratio in peripheral blood correlates with successful withdrawal of immunosuppression in liver transplant patients. Am. J. Transplant. 3, 689–696.
Tanaka, M., Zwierzchoniewska, M., Mokhtari, G. K., et al. (2005) Progression of alloresponse and tissue-specific immunity during graft coronary artery disease. Am. J. Transplant. 5, 1286–1296.
Vela-Ojeda, J., Garcia-Ruiz Esparza, M. A., Reyes-Maldonado, E., et al. (2006) Clinical relevance of NK, NKT, and dendritic cell dose in patients receiving G-CSF-mobilized peripheral blood allogeneic stem cell transplantation. Ann. Hematol. 85, 113–120.
Vakkila, J., Thomson, A. W., Hovi, L., Vettenranta, K., and Saarinen-Pihkala, U. M. (2005) Circulating dendritic cell subset levels after allogeneic stem cell transplantation in children correlate with time post transplant and severity of acute graft-versus-host disease. Bone Marrow Transplant. 35, 501–507.
Panse, J. P., Heimfeld, S., Guthrie, K. A., et al. (2005) Allogeneic peripheral blood stem cell graft composition affects early T-cell chimaerism and later clinical outcomes after non-myeloablative conditioning. Br. J. Haematol. 128, 659–667.
Danna, E. A. and Nolan, G. P. (2006) Transcending the biomarker mindset: deciphering disease mechanisms at the single cell level. Curr. Opin. Chem. Biol. 10, 20–27.
Krutzik, P. O., Hale, M. and Nolan, G. P. (2005) Characterization of the murine immunological signaling network with phosphospecific flow cytometry. J. Immunol. 175, 2366–2373.
Traggiai, E., Chicha, L., Mazzucchelli, L., et al. (2004) Development of a human adaptive immune system in cord blood cell-transplanted mice. Science 304, 104–107.
Lan, P., Tonomura, N., Shimizu, A., Wang, S., and Yang, Y. G. (2006) Reconstitution of a functional human immune system in immunodeficient mice through combined human fetal thymus/liver and CD34+ cell transplantation. Blood 108, 487–492.
Utz, P. J. (2005) Protein arrays for studying blood cells and their secreted products. Immunol. Rev. 204, 264–282.
Voshol, H., Brendlen, N., Muller, D., et al. (2005) Evaluation of biomarker discovery approaches to detect protein biomarkers of acute renal allograft rejection. J. Proteome Res. 4, 1192–1199.
Mansfield, E. S. and Sarwal, M. M. (2004) Arraying the orchestration of allograft pathology. Am. J. Transplant. 4, 853–862.
Kurian, S. M., Flechner, S. M., Kaouk, J., et al. (2005) Laparoscopic donor nephrectomy gene expression profiling reveals upregulation of stress and ischemia associated genes compared to control kidneys. Transplantation 80, 1067–1071.
Matsui, Y., Saiura, A., Sugawara, Y., et al. (2003) Identification of gene expression profile in tolerizing murine cardiac allograft by costimulatory blockade. Physiol. Genomics 15, 199–208.
Oertelt, S., Selmi, C., Invernizzi, P., Podda, M., and Gershwin, M. E. (2005) Genes and goals: an approach to microarray analysis in autoimmunity. Autoimmun. Rev. 4, 414–422.
Perrier, P., Martinez, F. O., Locati, M., et al. (2004) Distinct transcriptional programs activated by interleukin-10 with or without lipopolysaccharide in dendritic cells: induction of the B cell-activating chemokine, CXC chemokine ligand 13. J. Immunol. 172, 7031–7042.
Griffin, M. D., Xing, N., and Kumar, R. (2004) Gene expression profiles in dendritic cells conditioned by 1alpha,25-dihydroxyvitamin D3 analog. J. Steroid Biochem. Mol. Biol. 89–90, 443–448.
Napolitani, G., Rinaldi, A., Bertoni, F., Sallusto, F., and Lanzavecchia, A. (2005) Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. Nat. Immunol. 6, 769–776.
Bennett, L., Palucka, A. K., Arce, E., et al. (2003) Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J. Exp. Med. 197, 711–723.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Raimondi, G., Turnquist, H.R., Thomson, A.W. (2007). Frontiers of Immunological Tolerance. In: Fairchild, P.J. (eds) Immunological Tolerance. Methods in Molecular Biology™, vol 380. Humana Press. https://doi.org/10.1007/978-1-59745-395-0_1
Download citation
DOI: https://doi.org/10.1007/978-1-59745-395-0_1
Publisher Name: Humana Press
Print ISBN: 978-1-58829-652-8
Online ISBN: 978-1-59745-395-0
eBook Packages: Springer Protocols